CDC recommends Pfizer/BioNTech Covid-19 vaccine boosters for children as young as 12

By: | January 6, 2022

The US Centers for Disease Control and Prevention updated its recommendations for the Pfizer/BioNTech Covid-19 vaccine booster on Wednesday to include children as young as 12, at least five months after they finish the primary vaccine series.

On Monday, the FDA expanded the emergency use authorization for Pfizer’s Covid-19 vaccine boosters to children ages 12 to 15. The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 13-1 earlier Wednesday in favor of recommending the expanded use of Covid-19 boosters for children in this age group.

The CDC had ​authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in ages 16 and 17 in December.